C12R 2001/34
Mycobacterium smegmatis
C12R2001/34 (Mycobacterium smegmatis) appears on 7 US grants and 8 published applications in this corpus.
Search patents in C12R- Granted patents
- 7
- Published applications
- 8
- Assignees
- 14
- Inventors
- 40
- Latest grant
- 15 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Genetically-engineered mycobacterium strain and a use thereof in the preparation of steroidal compounds15 Sep 2020US 10,774,355 B2East China University of Science and Technology
- Mycobacterium tuberculosis ΔESX-3 mutants2 May 2017US 9,637,749 B2Albert Einstein College of Medicine
- Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore13 May 2008US 7,371,571 B2Board of Regents, University of Nebraska-Lincoln
- Attenuated recombinant mycobacteria useful as immunogens or as vaccine components17 Jul 2001US 6,261,568 B1Institut Pasteur
- Vectors and prokaryotes which autocatalytically delete antibiotic resistance7 Apr 1998US 5,736,367 AMedImmune, LLC
- Amplifiable metabolic labeling for detection of bacterial viability, growth and antibiotic susceptibility2 Jan 2025US 2025/0002970 A1University of Massachusetts
- Control of subunit stoichiometry in single-chain msp nanopores28 Nov 2024US 2024/0391963 A1The UAB Research Foundation
- Mycobacterium tuberculosis (mtb) adenosine triphosphate (atp) synthase-expressing recombinant bacterium, and construction method and expression method thereof31 Oct 2024US 2024/0360459 A1Nankai University
- Novel recombinant strain of mycobacterium smegmatis and use of same23 May 2024US 2024/0165216 A1Clipsbnc Co., Ltd.
- A Genetically-Engineered Mycobacterium Strain And A Use Thereof In The Preparation Of Steroidal Compounds29 Aug 2019US 2019/0264249 A1East China University of Science and Technology
Most cited
By later US patents
- Vectors and prokaryotes which autocatalytically delete antibiotic resistance12US 5,736,367 AMedImmune, LLC · 1998
- Attenuated recombinant mycobacteria useful as immunogens or as vaccine components9US 6,261,568 B1Institut Pasteur · 2001
- Process for preparing polyprenyl carboxylic acid derivatives2US 4,474,881 AAgency of Industrial Science and Technology · 1984
- Polyprenyl carboxylic acid derivatives2US 4,500,463 AAgency of Industrial Science and Technology · 1985